Wednesday - November 19, 2025

Category Archives: Marketing & Sales

Hyperphosphatemia Market Size was ~ USD 4 billion in 2023, estimates DelveInsight

Hyperphosphatemia Market Hyperphosphatemia companies are Phosphate Therapeutics, Bayer, Shire, Kyowa Kirin Co Ltd, Shanghai Alebund Pharmaceuticals Limited, Ardelyx, Kissei Pharmaceutical Co. Ltd., Taisho Pharmaceutical Co. Ltd., Sanofi, Chugai Pharmaceutical, Astellas Pharma Inc., Alebund Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation, KDL Inc., … Continue reading →

Muscle Invasive Bladder Cancer Competitive Landscape 2025: Clinical Trials, Sales Forecast, Revenue Share, Medication, Treatment, Companies by DelveInsight

Muscle Invasive Bladder Cancer Competitive Landscape Muscle Invasive Bladder Cancer companies are Merck Sharp & Dohme LLC, Aura Biosciences, Janssen Research & Development, LLC, Asieris Pharmaceuticals, RemeGen Co., Ltd. and others. The Muscle Invasive Bladder Cancer (MIBC) pipeline is rapidly … Continue reading →

Stellar Hits Studio Unveils Exclusive Holiday Collections and Unbeatable Deals Ahead of the 2025 Season

Stellar Hits Studio launches its 2025 holiday collections featuring mindset boosters, advanced tech gadgets, pet supplies, top 30 best-sellers, and exclusive Super Deals. With major seasonal events like Thanksgiving, Black Friday, Cyber Monday, and Christmas approaching, shoppers can enjoy premium … Continue reading →

From Hardship to Healing: Paula B. Shares Her Inspiring True Story in Poverty to Power

In her powerful debut memoir, Poverty to Power, Paula B. invites readers into a moving, faith-filled journey through childhood abandonment, early motherhood, heartbreak, and redemption. With raw honesty and heartfelt reflection, Paula reveals how she transformed pain into purpose—offering hope … Continue reading →

Non-Cystic Fibrosis Bronchiectasis Market is expected to reach USD 5,768 million by 2034, estimates DelveInsight

Non-Cystic Fibrosis Bronchiectasis Market Non-Cystic Fibrosis Bronchiectasis companies working in the market are Insmed, AstraZeneca, Zambion, The Marcus Foundation, Inc., Chiesi Farmaceutici S.p.A., SolAeroMed Inc., Zambon SpA, Boehringer Ingelheim, Renovion, Inc., Novartis, Alaxia SAS, and others.   The NCFB market … Continue reading →

Intratumoral Cancer therapies Market is expected to Reach USD 4.19 billion by 2034, Estimates DelveInsight

Intratumoral Cancer therapies Market Key companies developing Intratumoral Cancer therapies are Amgen, Daiichi Sankyo, AiViva BioPharma, Lytix Biopharma, Regeneron Pharmaceuticals, Checkmate Pharmaceuticals, OncoSec Medical Incorporated, Merck, Istari Oncology, Replimune, Philogen, Sirnaomics, Exicure, Intensity Therapeutics, NanOlogy, Nanobiotix, Immunovative Therapies, DNAtrix, Idera … Continue reading →

Acute Ischemic Stroke Market size was ~USD 1.3 Billion in 2023, estimates DelveInsight

Acute Ischemic Stroke Market size Leading Acute Ischemic Stroke companies are Acticor Biotech, DiaMedica Therapeutics, Lumosa Therapeutics, Bristol Myers Squibb, Janssen Pharmaceutical, Genentech Inc., Athersys, Healios K.K., NoNO Inc., Bayer, ZZ Biotech, Biogen Inc., Revalesio Corporation, AbbVie, TrueBinding Inc., Silver … Continue reading →

Myasthenia Gravis Market is expected to grow at a CAGR of 10.4% by 2034, estimates DelveInsight

Myasthenia Gravis Market Myasthenia Gravis companies such as Hoffmann-La Roche, Immunovant Sciences GmbH, Horizon Therapeutics, Amgen, Janssen Research & Development, Alexion, AstraZeneca Rare Disease, Regeneron Pharmaceuticals, Kyverna Therapeutics, Cartesian Therapeutics, Dianthus Therapeutics, Takeda, COUR Pharmaceuticals, and others. The myasthenia gravis … Continue reading →